Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-02 to 2025-01-03
Current total value of award: $1268.38
Description: 4566820302!XIFAXAN 550 MG TABLET UD 60S